Front Matter; Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets; Trial Designs and Outcomes to Monitor Novel Therapeutics in Alzheimer's Disease; The Pharmacological Treatment of Alzheimer's Disease with Cholinesterase Inhibitors and Memantine; M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease; Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy; The Rationale for Glutamatergic Therapy in Alzheimer's Disease; Secretases as Pharmacological Targets in Alzheimer's Disease.
0
Examines the strategies to develop effective therapies for Alzheimer's disease, a neurodegenerative condition. This book discusses a wide range of pharmacological mechanisms underlying these therapies. It is useful for researchers, scientists, clinicians, and graduate students in the pharmaceutical sciences and pharmacology and neuroscience.
MIL
114145
Pharmacological mechanisms in Alzheimer's therapeutics.